Contemporary Pediatrics week in review: FDA-approved generics for ADHD, changing the RSV prevention landscape, and more

News
Article

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Contemporary Pediatrics week in review: FDA-approved generics for ADHD, changing the RSV prevention landscape, and more | Image Credit: Contemporary Pediatrics

Contemporary Pediatrics week in review: FDA-approved generics for ADHD, changing the RSV prevention landscape, and more | Image Credit: Contemporary Pediatrics

Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, August 28 to Friday, September 1, 2023) and click each link to read and watch anything you may have missed.

1.) Changing the RSV prevention landscape

From a virus that had no treatment options, to one that may be prevented in two different modalities, clinicians are hoping to see a reduction in respiratory syncytial virus (RSV) incidence rates, starting this fall.

Click here for the full article.

2.) FDA approves multiple lisdexamfetamine dimesylate generics for ADHD in children

Patients 6 years and up with ADHD now have alternate options for prescription lisdexamfetamine dimesylate (Vyvanse; Takeda Pharmaceuticals USA Inc), after the FDA-approval of multiple generic options.

Click here for the full article.

3.) Original mRNA vaccines helped protect children against COVID-19-associated ED visits

According to a recent Morbidity and Mortality Weekly Report, the original COVID-19 monovalent and bivalent vaccines helped reduce emergency department or urgent care encounters for children aged 6 months to 5 years.

Click here for the full article.

4.) How are gut microbiomes and pediatric neurological, cognitive conditions being linked?

Rob Knight, PhD, Wolfe Endowed Chair in Microbiome Science at Rady Children's Hospital-San Diego, professor of pediatrics, UCSD, explains how links between gut microbiomes and cognitive and neurological conditions are being researched and what could be ahead for these associations in children.

Click here to watch the full video.

5.) Stigmas, structure are the biggest school days challenges of diabetes management

A new report examined the challenges of diabetes management during the school years from the perspective of the daily social and institutional challenges children face.

Click here for the full article.

Related Videos
DB-OTO improved hearing to normal in child with profound genetic deafness | Image Credit: © Marija - © Marija - stock.adobe.com.
Perry Roy, MD
Perry Roy, MD | Image Credit: Carolina Attention Specialists
Juanita Mora, MD
Lauren Flagg
Ashley Gyura, DNP, CPNP-PC | Image Credit: Children's Minnesota
Traci Gonzales, MSN, APRN, CPNP-PC
Related Content
© 2024 MJH Life Sciences

All rights reserved.